(Q28570112)

2

1 reference

31 January 2017

Li-Ping Wang

3

1 reference

31 January 2017

Gui-Rong Li

4

1 reference

31 January 2017

Xiu-Ling Deng

Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes

5

1 reference

31 January 2017

1 December 2012

1 reference

31 January 2017

1 reference

31 January 2017

464

1 reference

31 January 2017

6

1 reference

31 January 2017

613–621

1 reference

31 January 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Left ventricular diastolic function in hypertension and role of plasma glucose and insulin. Comparison with diabetic heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Cell cycle-dependent expression of potassium channels and cell proliferation in rat mesenchymal stem cells from bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

What mechanisms underlie diastolic dysfunction in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Calcium- and superoxide anion-mediated mitogenic action of substance P on cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Extracellular matrix maturation in the left ventricle of normal and diabetic swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Diabetic cardiomyopathy: the search for a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

New type of cardiomyopathy associated with diabetic glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Experimental diabetes mellitus down-regulates large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle and alters functional conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Advanced glycation end product in familial amyloidotic polyneuropathy (FAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-012-1165-0

Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts

21 January 2018

1 reference

12 December 2020

Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle

1 reference

12 December 2020

Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.

1 reference

12 December 2020

Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes

1 reference

12 December 2020

Diabetic cardiomyopathy

1 reference

12 December 2020

10.1007/S00424-012-1165-0

Identifiers

DOI

1 reference

31 January 2017

Dimensions Publication ID

1009621378

0 references

Fatcat ID

release_dh4zu7e7jrad3msop37thk7gyi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dh4zu7e7jrad3msop37thk7gyi

24 November 2022